Literature DB >> 4152206

Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice.

E J Yunis, R A Good, J Smith, O Stutman.   

Abstract

Long-lived, immunologically vigorous (C3H(f) x A(f))F(1) hybrids were produced after lethal irradiation by administration of spleen cells from C3H(f) or syngeneic donors. Further, neonatally thymectomized C3H(f) or A(f) strain donors reconstituted irradiated C3H(f) or (C3H(f) x A(f))F(1) hosts. In addition, C3H(f) spleen cells from nonthymectomized 10- to 15-day-old donors protected irradiated hybrid mice, but A(f) cells of young mice as well as of older mice produced graft-versus-host reaction and early death in irradiated C3H(f) or (C3H(f) x A(f))F(1) hybrids. Abrogation of secondary disease by treatment of irradiated mice with spleen cells from allogeneic neonatally thymectomized mice is possibly attributable to diminished immunologic competence of the cells grafted, followed by the development of immunological tolerance of the donor cells. Donor cells, receiving thymus influence in the recipient host after transplantation, could explain the long-lived immunologically vigorous radiation chimeras that did not experience graft-versus-host reactions. The findings of this study help to understand the differential susceptibility of A(f) and C3H(f) mice to development of tolerance to one another's antigens observed in prior investigations. It appears that, in these mice, the host thymus influences the maturation of the spleen cells from young mice or from neonatally thymectomized mice. However, this influence was often greater in mice given 767 rads than in those given 1046 rads. This differential influence is possibly attributable to irradiation damage to the thymus produced by the higher dose of irradiation. Spleen cells from neonatally thymectomized mice can be differentiated and expanded by the thymus of the host. The differential susceptibility of T(1), early differentiation stages, of thymus-dependent lymphocytes and T(2), late differentiation stages, of thymus-dependent lymphocytes to tolerance induction and immunostimulation, respectively, are proposed as the bases for these otherwise paradoxical influences.

Entities:  

Mesh:

Year:  1974        PMID: 4152206      PMCID: PMC388496          DOI: 10.1073/pnas.71.6.2544

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  "Secondary disease" of radiation chimeras: a syndrome due to lymphoid aplasia.

Authors:  D W BARNES; J F LOUTIT; H S MICKLEM
Journal:  Ann N Y Acad Sci       Date:  1962-10-24       Impact factor: 5.691

2.  The pathogenesis of the secondary disease after foreign bone marrow transplantation in X-irradiated mice.

Authors:  D van BEKKUM; O VOS; W W WEYZEN
Journal:  J Natl Cancer Inst       Date:  1959-07       Impact factor: 13.506

3.  Three closely linked genetic systems relevant to transplantation.

Authors:  E J Yunis; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

4.  Bone marrow transplantation in man.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; K Nouza; Y Hrask
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

5.  Experimental aspects of bone marrow transplantation in primates.

Authors:  H Balner; K A Dicke; L M van Putten; D W van Bekkum
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

6.  Multiple MLC (LD) determinants on the same HL-A haplotype.

Authors:  B Dupont; C Jersild; G S Hansen; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

7.  Graft versus host inhibition: fetal liver and thymus cells to minimize secondary disease.

Authors:  M M Bortin; E C Saltzstein
Journal:  Science       Date:  1969-04-18       Impact factor: 47.728

8.  Reversal of post-thymectomy wasting disease in mice by multiple thymus grafts.

Authors:  O Stutman; E J Yunis; C Martinez; R A Good
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

9.  Two separate genes controlling stimulation in mixed lymphocyte reaction in man.

Authors:  B Dupont; R A Good; G S Hansen; C Jersild; L S Nielsen; B H Park; A Svejgaard; M Thomsen; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

10.  Carcinogen-induced tumors of the thymus. IV. Humoral influences of normal thymus and functional thymomas and influence of posthymectomy period on restoration.

Authors:  O Stutman; E J Yunis; R A Good
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

View more
  6 in total

Review 1.  T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

Authors:  R J O'Reilly; G Koehne; A N Hasan; E Doubrovina; S Prockop
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Protection of lethally irradiated mice with allogeneic fetal liver cells: influence of irradiation dose on immunologic reconstitution.

Authors:  O Tulunay; R A Good; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Treatment of severe combined immunodeficiency by transplantation.

Authors:  D Niethammer
Journal:  Blut       Date:  1981-03

4.  Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation.

Authors:  P J Martin; J A Hansen; E D Thomas
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

5.  Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance.

Authors:  M Sykes; M A Sheard; D H Sachs
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

6.  Influence of milk source on transplantability of histocompatible mammary tumours in mice.

Authors:  D Oth; D Sabolovic
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.